MyFinsight
Home
Blog
About
Contact
Download
Download image
License receivable from
genevant
$178,741K
Investments in marketable
short-term securities
$71,520K
Cash and cash
equivalents
$23,706K
Prepaid expenses and
other current assets
$1,732K
Accounts receivable
$1,312K
Total current assets
$277,011K
Other non-current
assets
$131K
Property and equipment,
net of accumulated...
$22K
Total assets
$277,164K
Total liabilities and
stockholders equity
$277,164K
Total stockholders
equity
$260,177K
Total liabilities
$16,987K
Deficit
-$1,210,378K
Accumulated other
comprehensive loss
-$48,195K
Issued and outstanding
196,947,757 (december 31,...
$1,444,494K
Contingent consideration
$8,604K
Total current
liabilities
$5,105K
Liability related to sale
of future...
$3,278K
Additional paid-in capital
$74,256K
Accounts payable and
accrued liabilities
$4,474K
Lease liability,
current
$631K
Back
Back
Balance Sheet
Arbutus Biopharma Corp (ABUS)
Arbutus Biopharma Corp (ABUS)
source: myfinsight.com